0
Intra-Cellular Therapies Inc Banner Image

Intra-Cellular Therapies Inc

  • Ticker ITCI
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intra-Cellular Therapies Inc Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). Its lead drug candidate is ITI-007, which is in phase III clinical development for the treatment of schizophrenia, behavioral disturbances in dementia, bipolar disorder, depressionMore, and other neuropsychiatric and neurological disorders.
REPORT RATINGS
4.8 / 5.0 (162)

Intra-Cellular Therapies Inc reports have an aggregate usefulness score of 4.8 based on 162 reviews.

Intra-Cellular Therapies Inc

Most Recent Annual Report

Intra-Cellular Therapies Inc
MOST RECENT 2022 Annual Report and Form 10K

Intra-Cellular Therapies Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Intra-Cellular Therapies Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!